About Bridget
Bridget Wang represents companies, investment banks and private equity funds in IPOs in the US and Hong Kong capital markets, pre-IPO equity investments, corporate governance of HKEX listed companies and other corporate transactions.
Prior to joining Cooley, Bridget practiced in the Shanghai office of a leading UK law firm and a PRC law firm.
Bridget is a native Mandarin speaker and is fluent in English.
Representative Matters:
Capital Markets
- Keymed Biosciences in its US$400 million IPO and listing on the main board of the Hong Kong Stock Exchange
- J.P.Morgan and Morgan Stanley as underwriters in Budweiser APAC’s US$5 billion IPO and listing on the main board of the Hong Kong Stock Exchange
- XD Inc. in its US$105 million IPO and listing on the main board of the Hong Kong Stock Exchange
- Morgan Stanley and Haitong International as underwriters in Hygeia Healthcare’s US$282 million IPO and listing on the main board of the Hong Kong Stock Exchange
- Morgan Stanley, Bank of America Securities and CLSA as underwriters on Harbour BioMed’s US$220 million IPO and listing on the main board of the Hong Kong Stock Exchange
HKEX compliance clients
- China Literature
- Haitong Securities
- Maoyan Entertainment
Education
Vrije University Amsterdam
LLM, 2017
Shanghai University of Political Science and Law
LLB, 2015